2966 Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices 

Need and Use of Information 

Collection: The OPEN Workforce 

Tracker database will gather and store 

information on neuroscience research 

trainees who have received NINDS 

support. The NINDS OPEN will use this 

information to analyze diversitytargeted career development program 

outcomes, to make improvements to 

these programs, and to build and foster 

a user-friendly community that will 

allow NINDS to communicate 

information and opportunities to 

current and former awardees, including 

those from groups that may be 

underrepresented and underserved 

within federal programs and awards. 

The OPEN Workforce Tracker will help 

NINDS collect structured information 

that is specific to the requirements of 

NINDS programs and that reflects 

outcome metrics used to assess program 

effectiveness. This information includes 

career stage, position, publications, 

degrees, and information related to NIH 

funding and external funding received, 

as well as protected class identifiers 

(race and ethnicity, sexual 

identification, gender, and disability) 

important for understanding program 

participation and outcomes across 

diverse groups. 

The tracker follows minimization 

principles: it only collects relevant and 

necessary information to accomplish the 

purposes of program evaluation and 

communication, and it will interface 

with and pull in relevant information 

from existing NIH database systems 

database systems to minimize reporting 

burden. The database grants NINDS 

awardees the right to access their data 

held by NINDS and the ability to copy 

and correct any information errors. The 

information collection is consistent with 

NINDS’s mission and mandate to 

conduct and support training in 

neuroscience (Public Health Service 

Act, 42 U.S.C. 285(j)). Also, this 

database aligns with the NIH-wide 

strategic plan to advance diversity, 

equity, inclusion, and accessibility 

(DEIA) through research and support 

analyses to identify and remove 

potential barriers to the implementation 

and expansion of promising and 

effective DEIA practices, policies, and 

procedures (Objective 3). 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

167. 

ESTIMATED ANNUALIZED BURDEN HOURS

Form name Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average 

burden per 

response 

(in hours) 

Total annual 

burden hour 

Trainee database .............................. Individuals (‘‘trainees’’) ..................... 500 1 20/60 167 

Total ........................................... ........................................................... ........................ 500 ........................ 167 

Dated: January 10, 2024. 

Paul A. Scott, 

Project Clearance Liaison, National Institute 

of Neurological Disorders and Stroke, 

National Institutes of Health. 

[FR Doc. 2024–00750 Filed 1–16–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Submission for OMB Review; 30-Day 

Comment Request; National Institute 

on Drug Abuse Adolescent Brain & 

Cognitive Development (ABCD) 

StudySM—Audience Feedback Teams 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: In compliance with the 

Paperwork Reduction Act of 1995, the 

National Institutes of Health (NIH) has 

submitted to the Office of Management 

and Budget (OMB) a request for review 

and approval of the information 

collection listed below. 

DATES: Comments regarding this 

information collection are best assured 

of having their full effect if received 

within 30-days of the date of this 

publication. 

ADDRESSES: Written comments and 

recommendations for the proposed 

information collection should be sent 

within 30 days of publication of this 

notice to www.reginfo.gov/public/do/ 

PRAMain. Find this particular 

information collection by selecting 

‘‘Currently under 30-day Review—Open 

for Public Comments’’ or by using the 

search function. 

FOR FURTHER INFORMATION CONTACT: To 

request more information on the 

proposed project or to obtain a copy of 

the data collection plans and 

instruments, contact: Dr. Kimberly 

LeBlanc, Scientific Program Manager, 

Division of Extramural Research, 

National Institute on Drug Abuse, C/O 

NIH Mail Center/Dock 11, 3WFN Room 

09C77, MSC 6021, Gaithersburg, MD 

20877 (20892 for USPS), or call non-tollfree number (301) 827–4102, or Email 

your request, including your address, to: 

kimberly.leblanc@nih.gov. 

SUPPLEMENTARY INFORMATION: This 

proposed information collection was 

previously published in the Federal 

Register on October 2, 2023, page 

67775–67776 (88 FR 67775) and 

allowed 60 days for public comment. No 

public comments were received. The 

purpose of this notice is to allow an 

additional 30 days for public comment. 

The National Institute on Drug Abuse 

(NIDA), National Institutes of Health, 

may not conduct or sponsor, and the 

respondent is not required to respond 

to, an information collection that has 

been extended, revised, or implemented 

on or after October 1, 1995, unless it 

displays a currently valid OMB control 

number. 

In compliance with section 

3507(a)(1)(D) of the Paperwork 

Reduction Act of 1995, the National 

Institutes of Health (NIH) has submitted 

to the Office of Management and Budget 

(OMB) a request for review and 

approval of the information collection 

listed below. 

Proposed Collection: Adolescent 

Brain & Cognitive Development (ABCD) 

StudySM—Audience Feedback Teams, 

0925—NEW, exp., date XX/XX/XXXX, 

National Institute on Drug Abuse 

(NIDA), National Institutes of Health 

(NIH). 

Need and Use of Information 

Collection: The purpose of this 

information collection request is to 

solicit audience feedback to improve the 

data collection process for the 

Adolescent Brain Cognitive 

Development (ABCD) Study. Started in 

2015, the ABCD Study® follows a cohort 

of over 10,000 young people from preadolescence into adulthood to 

understand how growing brains are 

shaped by experiences and biology. To 

prepare for each year’s Study data 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 89, No. 11 / Wednesday, January 17, 2024 / Notices 2967 

collection, the National Institute of 

Health is collecting audience feedback 

on a selection of survey questions and 

research protocols. Parents/caregivers 

and teens who are the same age as the 

study cohort members but who are not 

Study participants will review proposed 

questions and give feedback on 

questions’ clarity and acceptability. 

Recommendations from these findings 

help the ABCD Study team improve 

their protocol for a more-successful data 

collection. 

Audience feedback activities will 

include a mix of asynchronous and 

scheduled, live data collection: webbased survey activities, virtual 

discussion boards, individual 

interviews, and discussions groups. 

Assembling a cohort of audience 

feedback participants who are familiar 

with the ABCD Study and participate in 

multiple data collection activities 

minimizes the burden required to 

familiarize new participants with the 

purpose of the Study and the 

expectations for audience feedback. 

OMB approval is requested for 3 

years. There are no costs to respondents 

other than their time. The total 

estimated annualized burden hours are 

172. 

ESTIMATED ANNUALIZED BURDEN HOURS

Type of respondent Number of 

respondents 

Number of 

responses per 

respondent 

Average time 

per response 

(in hours) 

Total annual 

burden hour 

Individuals (Parent/Caregiver Phone Screener) .......................................... 72 1 5/60 6 

Individuals (Parent/Caregiver Consent) ....................................................... 15 1 5/60 1 

Individuals (Parent/Caregiver Permission for Teen Participation) ............... 36 1 5/60 3 

Individuals (Teen Phone Screener) ............................................................. 72 1 5/60 6 

Individuals (Teen Assent or Consent) ......................................................... 36 1 10/60 6 

Individuals (Teen Web Survey) ................................................................... 36 2 30/60 36 

Individuals (Parent/Caregiver Web Survey) ................................................ 15 2 30/60 15 

Individuals (Teen Virtual Group Discussion or Online Bulletin Board) ....... 36 2 1 72 

Individuals (Parent/Caregiver Virtual Interview) .......................................... 15 1 30/60 8 

Individuals (Parent/Caregiver Online Bulletin Board) .................................. 15 1 1 15 

Individuals (Parent/Caregiver ‘‘At-Home’’ Materials Review) ...................... 15 1 15/60 4 

Total ...................................................................................................... ........................ 450 .......................... 172 

Lanette A. Palmquist, 

Project Clearance Liaison, National Institute 

on Drug Abuse, National Institutes of Health. 

[FR Doc. 2024–00760 Filed 1–16–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meetings 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; HHS–NIH–CDC–SBIR PHS 

2024–1 Phase I: Novel Diagnostic Biomarker 

Discovery and Validation for Malaria and 

Select Neglected Tropical Diseases (NTDs) 

(Topic 132). 

Date: February 15, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G13A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Mairi Noverr, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G13A, Rockville, MD 

20852, (240) 747–7530, mairi.noverr@

nih.gov. 

Name of Committee: National Institute of 

Allergy and Infectious Diseases Special 

Emphasis Panel; Small Business Innovation 

Research (SBIR) Phase II Program Contract 

Solicitation (PHS 2022–1) Topic 108— 

Development of Rapid POC Diagnostics for 

Treponema pallidum (N01). 

Date: February 16, 2024. 

Time: 9:00 a.m. to 5:00 p.m. 

Agenda: To review and evaluate contract 

proposals. 

Place: National Institute of Allergy and 

Infectious Diseases, National Institutes of 

Health, 5601 Fishers Lane, Room 3G13A, 

Rockville, MD 20892 (Virtual Meeting). 

Contact Person: Mairi Noverr, Ph.D., 

Scientific Review Officer, Scientific Review 

Program, Division of Extramural Activities, 

National Institute of Allergy and Infectious 

Diseases, National Institutes of Health, 5601 

Fishers Lane, Room 3G13A, Rockville, MD 

20852, (240) 747–7530, mairi.noverr@

nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.855, Allergy, Immunology, 

and Transplantation Research; 93.856, 

Microbiology and Infectious Diseases 

Research, National Institutes of Health, HHS) 

Dated: January 11, 2024. 

Lauren A. Fleck, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2024–00773 Filed 1–16–24; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute of Allergy and 

Infectious Diseases; Notice of Closed 

Meeting 

Pursuant to section 1009 of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The contract proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the contract 

proposals, the disclosure of which 


lotter on DSK11XQN23PROD with NOTICES1